Whitehawk Therapeutics
WHWK
65 hedge funds and large institutions have $26.8M invested in Whitehawk Therapeutics in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 19 closing their positions.
127% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 11
47% more call options, than puts
Call options by funds: $25K | Put options by funds: $17K
5.89% less ownership
Funds ownership: 60.06% → 54.16% (-5.9%)
11% less funds holding
Funds holding: 73 → 65 (-8)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
64% less capital invested
Capital invested by funds: $75.3M → $26.8M (-$48.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.37M |
| 2 |
6CM
683 Capital Management
New York
|
+$839K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$719K |
| 4 |
Renaissance Technologies
New York
|
+$641K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$371K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$3.78M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$3.1M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.61M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$1.49M |
| 5 |
DMKJ
David M. Knott Jr
|
-$1.28M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
76
Annandale Capital
Dallas,
Texas
| – | -$24K | -5,000 | Closed |
|
77
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$6.73K | -1,391 | Closed |
|
|
BTI
78
Blue Trust Inc
Alpharetta,
Georgia
| – | -$5K | -705 | Closed |
|
|
OA
79
Operose Advisors
Milwaukee,
Wisconsin
| – | -$2.42K | -500 | Closed |
|
80
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1.19K | -245 | Closed |
|
81
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$513 | -106 | Closed |
|
82
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$222 | -53 | -68% |
|
|
C
83
Covestor
London,
United Kingdom
| – | +$4 | +1 | +11% |
|
|
AW
84
Avion Wealth
The Woodlands,
Texas
| – | +$88 | +21 | +25% |
|
WHWK Hedge Fund Activity: Q4 2023 in Review
65 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q4 2023, worth a combined $26.8M — down 64% from $75.3M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of WHWK and 12 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 25 added.
The largest buyer was Morgan Stanley, adding an estimated $3.37M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $3.78M sold.
- 65 institutional investors held Whitehawk Therapeutics (WHWK) as of Q4 2023, down from 73 in Q3 2023.
- Funds reported $26.8M of Whitehawk Therapeutics stock for Q4 2023, down 64% quarter-over-quarter.
- 12 funds opened new Whitehawk Therapeutics positions in Q4 2023 and 19 closed out, a net change of -7 holders.
- The largest Whitehawk Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $3.37M added.
- The largest Whitehawk Therapeutics seller in Q4 2023 was Janus Henderson Group, an estimated $3.78M sold.
Based on aggregated 13F filings for Q4 2023.